The recent challenges in global distribution have highlighted the importance of securing critical medications like Ivermectin. Trusting on overseas manufacturers exposes regions to potential vulnerabilities, including shipping delays, expense fluctuations, and even geopolitical threats. Shifting towards domestic production of Ivermectin offers a mu